Location:Room Paris, North Hall (Level 1)
Individualized therapy in prostate cancer should be based on our knowledge about overexpressed oncogenes. The session will highlight importance of the transcription factor ERG and cytokines which may be targeted in experimental models and in clinical settings. Furthermore, the speakers will address issues related to scientific background of radiation therapy in prostate cancer.
Institutes: 1University College Dublin, Systems Biology Ireland, Dublin, Ireland, 2Memorial Sloan-Kettering Cancer Center, Weill Cornell Graduate School of Medical Sciences, New York City, United States of America, 3ETH Zurich, Institute of Molecular Systems Biology, Zurich, Switzerland, 4Dana-Farber Cancer Institute, CBio Center At Dana-Farber, Boston, United States of America
Institutes: Vancouver Prostate Centre, Dept. of Urology, Vancouver, Canada